MP
Mirum Pharmaceuticals, Inc.
SEC filingBiotechnology · Foster City, CA
Amount raised$68.5Msold at filing
Total offering$68.5M
Investors in the raise2count reported to the SEC
FiledJan 29, 2026first sale Jan 23, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Michael C. GreyDirector
Timothy WalbertDirector
Saira C. RamasastryDirector
Lon C. CardonDirector
Laurent C. FischerDirector
Eric BjerkholtExecutive Officer
William C. FaireyDirector
Christopher PeetzExecutive Officer, Director
Peter RadovichExecutive Officer
Laura BregeDirector
Patrick C. HeronDirector
Executive officers, directors and promoters as listed on the Form D.